P23 ‐ Boy with severe atopic dermatitis treated with omalizumab
| Autor: | Vassiliki Aggelakou, Emmanouel Manousakis, Amalia Tsilimigaki, Evangelia Stefanaki |
|---|---|
| Rok vydání: | 2014 |
| Předmět: |
Pulmonary and Respiratory Medicine
Allergy Pediatrics medicine.medical_specialty business.industry Immunology Disease Omalizumab Atopic dermatitis medicine.disease Dermatology Tacrolimus Poster Presentation medicine Immunology and Allergy Itching medicine.symptom business Asthma medicine.drug Fluticasone |
| Zdroj: | Clinical and Translational Allergy |
| ISSN: | 2045-7022 |
| DOI: | 10.1186/2045-7022-4-s1-p78 |
| Popis: | Atopic dermatitis (AD) is a common inflammatory, itching skin disease. In a subgroup of patients, the disease is recalcitrant to topical therapy and systemic treatments become necessary. Biological agents are a new approach in AD therapy. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full text from SpringerLink